CLINICAL PROBLEM
Fever is a common complaint in children. In most cases, fevers are due to selflimited viral infections and require no more than symptomatic treatment. Sometimes fever is due to common bacterial infections that are diagnosed by history and physical examination and require antibiotic treatment without laboratory evaluation. In a few clinical situations, the cause of fever is not easily identified. Fever without a source (FWS) may need further evaluation that includes laboratory tests or imaging. Rarely, the fever is more prolonged, requires more intensive evaluation, and falls in the category of fever of unknown origin (FUO) .
There is often confusion about the terms FUO and FWS. Distinguishing between FUO and FWS is important and is based on duration of fever. FWS can progress to FUO if no cause is elicited after 1 week of fever.
The current incidence and prevalence of pediatric FUO remain unclear. Several factors contribute to the difficulty in determining the epidemiology, including the lack of a standardized definition, clinical criteria, and coding using the International Classification of Diseases-9 code for the condition. Furthermore, the causes of FUO often have an overlapping collection of symptoms and insidious disease courses. The general direction of the evaluation varies based on patient presentation, geographic location, associated symptoms, environmental exposures, physician experience, and available testing techniques.
FEVER PHYSIOLOGY
Body temperature is primarily controlled by the hypothalamus via regulation of pulmonary, skin, and metabolic systems. A basic understanding of the physiologic factors regulating temperature can help distinguish between normal variance and fever. The mean basal temperature varies according to age, gender, body habitus, AUTHOR DISCLOSURE Drs Antoon, Potisek, and Lohr have disclosed no financial relationships relevant to this article. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device. time of day, activity level, menstrual cycle, and other factors.
(1)(2) Importantly, physiologic temperature exhibits a morning nadir and an early evening peak, which can vary by as much as 1ºC. Furthermore, infants and young children maintain higher temperatures than older children and adults, primarily because of increased metabolic rate and body surface-to-weight ratio. (1)(3) Of note, core body temperature is positively related to obesity, which should be taken into account with the growing number of obese children in the United States.
Fever generally is defined as a core temperature of at least 38.0ºC (100.4ºF) and is the result of a complex series of signalling cascades initiated in response to specific biologic stimuli. (2) Fever is believed to provide an evolutionary advantage in fighting off infection. Bacteria and viruses are heat sensitive and exhibit temperature-dependent toxin production, growth, and response to antibiotics. (4)(5) The body's mechanism of increasing core temperature in response to infection functions to ward off the offending microbes. Increased metabolic rate accelerates immune system mobilization, lymphocyte transformation, lysosome and neutrophil activity, and phagocytosis. Increases in lipolysis and proteolysis diminish the amount of free glucose that can be used by invading organisms. Similarly, the body transiently removes iron, zinc, and copper, critical cofactors in viral and bacterial replication, from the blood in response to the presence of fever. (6) Taken together, the fever response provides a natural defense mechanism against invading pathogens.
DEFINITION OF FEVER OF UNKNOWN ORIGIN
One of the challenges in investigating and reviewing FUO is the lack of a standard definition. The number of fever days before considering FUO historically ranged from 5 to 21 and required some degree of medical evaluation. (7)(8) The original literature included a lengthy time course of up to 3 weeks, but the advent of improved and rapid laboratory techniques has led to a shortened number of fever days before considering FUO diagnoses. With the availability of rapid molecular diagnostic techniques for many infections, most of the common causes of FUO from the past can now be diagnosed or excluded rapidly, which has shortened the time that is required to move from FWS to FUO.
FUO has more recently been defined as a temperature higher than 38.0°C (100.4°F) that lasts longer than at least 8 days without a clear source. (9) Although most children meeting the definition of FUO would have had some laboratory assessment, it is not currently a prerequisite. (10) However, any previous evaluation would help to broaden or narrow the differential diagnosis.
CAUSES
FUO remains a diagnostic dilemma for many pediatricians because it is frequently difficult to distinguish clinically between benign and potentially life-threatening causes. The spectrum of FUO causes is broad and includes infectious, autoimmune, oncologic, neurologic, genetic, factitious, and iatrogenic (Fig 1) . Pediatricians face the significant challenge of not missing the diagnosis of a serious illness or an easily treatable condition that can result in increased morbidity. Fortunately, FUO is usually an uncommon presentation of common diseases, most of which are easily treatable without increased morbidity.
Relatively few studies document the cause of FUO in developed countries; most of the current knowledge is derived from three studies performed almost 4 decades ago. (11)(12)(13) Low patient numbers and narrow patient populations in more recent studies limit the value of conclusions. (14) The sentinel studies on pediatric FUO in the United States found that approximately 90% of cases had an identifiable cause: approximately 50% infectious, 10% to 20% collagenvascular, and 10% oncologic. (11)(12)(13) Smaller subsequent studies from the 1990s had highly variable results: 20% to 44% infectious, 0% to 7% collagen-vascular, 2% to 3% oncologic, and up to 67% undiagnosed. (14)(15) The reason for this seemingly paradoxic increase in undiagnosed cases of FUO in the setting of improved diagnostic techniques is unclear. However, the shift from infectious to unidentifiable causes of FUO correlates with advances in diagnostic testing, including wider availability and rapid turnaround time. The advent of polymerase chain reaction, improved culture techniques, and better understanding of atypical viral and bacterial pathogenesis and autoimmune processes likely contribute to earlier diagnosis of the cause of FWS and fewer children advancing to the category of FUO. This shift to unidentifiable causes due to laboratory advances is supported by recent studies from developing countries with significant laboratory limitations, which show primarily infectious causes of FUO, similar to those of older studies in developed countries. (20)(21)(22)(23)(24) Most cases of "undiagnosed" FUO appear to be benign, with many resolving spontaneously without a confirmed Vol. 36 No. 9 S E P T E M B E R 2 0 1 5cause. These cases possibly consist of prolonged viral syndromes or difficult-to-confirm atypical bacterial infections. Substantially more evidence in the adult population supports the dynamic etiology of FUO over time, with multiple studies over several decades demonstrating an increasing trend toward undiagnosed cases. Some studies suggest that as many as 50% of adult FUO cases remain undiagnosed. (18)(19) These investigations also show decreased infectious and increased inflammatory diagnoses in the adult population over the same period of time. A better understanding of the current etiologic categories of FUO in children should improve the ability of medical practitioners to generate a differential diagnosis. In published studies with greater than 49 patients, infection (36%-78%) was by far the most common cause compared to other causes such as malignancy (2%-12%), collagen-vascular (2%-21%), miscellaneous noninfectious (2%-50%), and unknown (12%-29%). Most of these infections were of bacterial or atypical bacterial origin in contrast to the more common viral causes in developed countries. A more recent report of FUO in Turkey revealed a similar composition, with infection being most common, followed by malignancy and collagen-vascular diseases. (23) A 2012 study of 95 pediatric patients in Iran demonstrated that collagenvascular diseases were more common causes than malignancy, but there was a high rate of undiagnosed cases. (26) Interestingly, Chantada et al (25) reviewed 113 cases of FUO in Argentina according to three age categories: 0 to 11 months, 12 to 59 months, and older than 60 months. Infection was the most common cause across all age groups, but infectious causes were less common in those ages 12 to 59 months compared to the other two age groups. Children ages 12 to 59 months had a corresponding increase in neoplastic and miscellaneous noninfectious causes of FUO. These results differed from a study of 80 patients in Turkey, which suggested a decreased likelihood of infectious causes with increasing age. (21) As with recent studies in developed countries, small sample sizes and variation in endemic infections limit generalization of these findings.
FEVER OF UNKNOWN ORIGIN IN DEVELOPING COUNTRIES
Several contributing and complicating factors are associated with the higher infectious burden of FUO in developing countries. The prevalence of certain infections known to cause FUO, such as human immunodeficiency virus (HIV), tuberculosis, leishmaniasis, and malaria, is higher in developing countries. Similarly, the rate of vaccinepreventable diseases is higher in developing compared to developed countries. Limited public health prevention programs and diminished access to health-care workers likely contribute to an increased incidence of infectious diseases as the cause for FUO, as does a decreased frequency of early recognition of infectious causes. Furthermore, limited awareness and ability to test for newly recognized causes of FUO, such as hemophagocytosis syndrome, may limit diagnosis of certain noninfectious causes.
EVALUATION
Initially distinguishing among infectious, autoimmune, malignancy, and miscellaneous causes of FUO may be difficult, but a thorough history and physical examination can often generate a directed differential diagnosis. We highly recommend a tiered approach to FUO to decrease overall costs and the use of invasive testing.
History and Physical Examination
Evaluation of FUO should be systematic and logically guided by history and physical examination findings. A detailed history, a thorough physical examination, and a proper interpretation of laboratory tests already performed are critical. The speed with which the evaluation should proceed and whether it should be outpatient or inpatient depends, in large part, on how ill the patient appears.
The first step in evaluating FUO is documentation that fever is actually present. Parental perception of fever often varies from the medical definition. It is useful to determine what the parent defines as fever and whether this varies from the medical definition of 38.0°C (100.4ºF). In our experience, parents frequently report tactile or subjective fevers without actually measuring the patient's temperature with an instrument. Parents should be asked if the temperature was checked using a thermometer.
Pseudo-FUO has been defined as successive episodes of benign, self-limited infections with fever that the parents perceive as one prolonged fever episode. (27) This needs to be carefully ruled out before undertaking an expensive and unnecessary evaluation. Usually, pseudo-FUO starts with a well-defined infection (most often viral) that resolves but is followed by other febrile viral illnesses that may be less well defined. Diagnosis of pseudo-FUO usually requires a careful history, focusing on identifying afebrile periods between febrile episodes. Differentiating pseudo-FUO from real FUO can be challenging. If pseudo-FUO is suspected and the patient does not appear ill, keeping a fever diary can be helpful. In rare situations, a basic laboratory evaluation may be necessary.
Any associated symptoms and the timing of antipyretic administration is particularly important. A detailed description of the patient's fever pattern as intermittent (eg, tuberculosis), recurrent (periodic fever disorders), relapsing (rat bite fever), remittent (endocarditis, juvenile idiopathic arthritis [JIA]), or sustained (pyogenic abscess) can sometimes narrow the differential diagnosis. (12)(13) Information on the frequency and timing of fevers can be helpful in determining the fever curve and ability to document the fever in the medical setting. Periodicity of fever and the presence of other symptoms at the time fever is present can aid in making certain diagnoses, such as periodic fever, aphthous stomatitis, pharyngitis, and adenopathy (PFAPA) or other periodic fever disorders, without further expensive evaluation. (28) Fever can be the initial presentation of certain immunodeficiency syndromes, but many affected patients have a history of repeated infections, diarrhea, or abnormal physical findings, such as a rash. A history of atopy or autoimmune disease increases the likelihood of an autoimmune or rheumatologic cause. Furthermore, neutropenic fever in certain situations can be a medical emergency, and the presence of neutropenia may broaden the potential infectious sources of fever while narrowing the diagnostic possibility (eg, cyclic neutropenia). Determining the patient's risk factors for neutropenic fever and any associated signs and symptoms is an important step in an evaluation of FUO.
Information regarding the ethnicity, race, family history, and genetic background of the patient can be helpful. Periodic fever disorders often run in families and are more common in certain ethnicities. For example, familial dysautonomia is most common in the Ashkenazi Jewish population whereas familial Mediterranean fever is seen in those of Arab, Jewish, Armenian, and Turkish descent. (29)(30) Geographic location and corresponding endemic pathogens known to cause FUO should be taken into consideration.
Vol. 36 No. 9 S E P T E M B E R 2 0 1 5For example, coccidioidomycosis is more common in the southwestern United States and 60% of the cases of Rocky Mountain spotted fever are reported from North Carolina, Oklahoma, Arkansas, Missouri, and Tennessee. Travel to or residence in these areas is an important clue for making these diagnoses. A thorough travel history is critical in the evaluation of FUO and should include exposure to animals, unusual foods, insect bites, and sick contacts. Even if there is no travel history, clinicians should determine the patient's overall exposure to any domestic or wild animals (eg, home, school, woods, playground, friend's or relative's house) rather than simply asking "Do you have any pets?" when evaluating for zoonoses (Table 1 ) (For a more extensive list of zoonoses, see the table of diseases transmitted by animals in the Red Book.) Similarly, a thorough history of any sick contacts or high-risk exposures (eg, recent travel to foreign countries, prisons, the homeless) can help narrow the differential diagnosis based on epidemiologic factors.
Many causes of FUO are accompanied by associated symptoms. A detailed review of systems and their timing in relation to fever can lead to a diagnosis. Because many patients with FUO will have received a variety of treatments, it is important to determine whether therapeutic interventions may have influenced the disease or fever course. This is particularly important because drug fever is one of the causes of FUO and simply discontinuing a chronically administered agent may lead to fever resolution.
The most important aspect of evaluation for FUO is repeated history taking and encouraging the patient and family to report any new, different, or unusual signs or symptoms regardless of how trivial they may seem. Most cases of FUO are diagnosed because important historical information guides the direction of further evaluation.
A thorough physical examination should be performed that documents vital signs and any reported weight loss. Physical signs commonly provide evidence of the underlying diagnosis (Table 2 ). Serial physical examinations should be performed, and observation in a controlled inpatient setting may be beneficial because up to 25% of significant physical findings may be absent at the time of presentation. 
Laboratory Studies and Imaging
A number of basic laboratory studies may be used to determine the source of FUO. A complete blood cell count (CBC) with differential count and smear can suggest an infectious or oncologic cause. Blood and urine cultures are recommended, with the understanding that repeat cultures may be needed. If the patient has neurologic symptoms, cerebrospinal fluid (CSF) studies are also indicated. Whenever possible, cultures should be obtained before initiating antibiotics to avoid ambiguity and contamination of results. Abnormalities in serum electrolytes or liver enzymes may indicate viral, atypical bacterial, or hematologic causes. Specific molecular testing for HIV, tuberculosis, or atypical bacterial pathogens and viral serologies is expensive and final results can be delayed days to weeks. These tests should be performed based on specific risk factors or suggestive physical findings.
Testing for acute-phase reactants, such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and ferritin, is common in the evaluation of FUO. These tests results are nonspecific and not diagnostic of any particular disorder. On the other hand, elevated acute-phase reactants should encourage the physician to proceed with further appropriate evaluation. Of note, normal acute-phase reactant results do not exclude serious causes of FUO.
The CRP is a ring-shaped protein, consisting of five subunits, that is synthesized by the liver in response to inflammation. Detectable elevation of serum CRP occurs within 6 hours of the trigger, heightens to a peak, and resolves quickly following resolution of the stimulus. (32) Physiologic levels of CRP vary based on age, gender, obesity, exercise tolerance, sleep deprivation, and stress levels. Therefore, clinicians should note the relative elevation of CRP from baseline in the patient rather than rely on a single initial value. CRP can be pathologically elevated in a wide variety of disease processes, including inflammatory, infectious, and autoimmune. There has been much interest in CRP as a predictor of serious bacterial infection, and current evidence suggests that a markedly elevated CRP is required for specificity for bacterial infection. (33)(34)(35)(36) When evaluating FUO, particularly in the hospital setting, mildly elevated CRP values should not be used to rule in or out a particular disease process. Trending CRP values are a more valuable diagnostic tool and can be used to evaluate treatment response and direct treatment modalities. (37) ESR responds to stimuli similar to those influencing CRP synthesis but is slower to elevate and has a longer half-life. ESR is an indirect measurement of serum acute-phase protein concentrations, and physiologic values vary based on age, gender, and other factors. Serum ESR may be altered in cases of abnormal serum protein concentrations, including fibrinogen, albumin, and immunoglobulin. In addition, ESR is subject to hemoglobin concentration and size, shape, and number of red blood cells. ESR is useful in determining chronic inflammation or infection, but for the previously stated reasons, it should be used with caution as a diagnostic tool, particularly in the setting of possible alterations in serum protein concentrations.
Ferritin is another acute-phase reactant. Elevated ferritin (in the absence of increased iron) may indicate an infectious, autoimmune, oncologic, or inflammatory process. (38) Some investigators have suggested that serum ferritin may be helpful in evaluation of FUO to distinguish between infectious and noninfectious causes. (39)(40) We have found that serum ferritin can be particularly helpful in diagnosing hemophagocytic lymphohistiocytosis (HLH), an increasingly recognized cause of pediatric FUO. (41) Recent guidelines have aided in the diagnosis of disease, and a serum ferritin value greater than 10,000 mg/mL is 90% sensitive and 96% specific for HLH. (42)(43) Radiographs and imaging may play a role in the evaluation of FUO, but research suggests that empiric imaging has limited utility. (15) Chest radiographs should be performed if pulmonary symptoms are present or if there is concern for atypical bacterial infection, HIV, tuberculosis, or oncologic processes. Additional imaging techniques, particularly computed tomography (CT) scan and magnetic resonance imaging (MRI), are associated with various risks and should be performed discriminately. CT scans are known to increase the risk of leukemia and brain tumors, particularly in the pediatric population, and MRI is time-consuming and often requires sedation in young children. (44) Therefore, we recommend judicious imaging with specific diagnoses in mind. For example, in a patient with gastrointestinal symptoms, weight loss, and elevated CRP/ESR, an abdominal CTscan may aid in the diagnosis of inflammatory bowel disease, abscess, or cancer. Of note, all patients with a potential malignancy should receive a chest radiograph to evaluate for a mediastinal mass before CT scan or MRI to avoid airway complications while lying supine for imaging.
Other imaging modalities, such as white blood cell (galliumor indium-111-labeled) scans, positron emission tomography, and immunoscintigraphy scanning, have not been well 
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Continued studied in the diagnosis of pediatric FUO. Limited evidence in children and additional studies in adults suggest that these techniques have low sensitivity and specificity in the evaluation of FUO and should be used only if traditional imaging fails to reveal a diagnosis. (45)(46)(47)(48) If fever persists and laboratory studies and imaging fail to reveal the underlying cause, invasive procedures may be necessary. Bone marrow biopsy can be performed to evaluate for oncologic or hematologic etiologies. Lumbar puncture, thoracentesis, joint aspiration, or biopsies may also be indicated to obtain fluid or tissue for analysis. These should be performed as a last resort in the non-acute patient.
Initial Diagnostic Approach
We recommend that the initial laboratory evaluation of pediatric FUO consist of a CBC, basic metabolic panel, The evaluation of FUO should be targeted if any findings on history, physical examination, or laboratory and imaging evaluation direct suspicion toward an organ system or diagnosis. A patient with known tick exposure, rash, and hyponatremia should receive serologic evaluation for Rocky Mountain spotted fever, Lyme disease, ehrlichiosis, anaplasmosis, or babesiosis, depending on the endemic region or travel history. (49) When deciding which laboratory tests to order, it is important to note that uncommon presentations of common diseases are more likely to cause FUO than uncommon or rare diseases. A well-appearing child with fever, rash, lymphadenopathy, and transaminitis is more likely to have Epstein-Barr virus or cytomegalovirus infection rather than HLH or systemic lupus erythematosus. In a nonacute patient, ruling out common causes of FUO before testing for uncommon causes or performing invasive testing can minimize the likelihood of dealing with false-positive, false-negative, or equivocal results for rare diseases.
We have established an initial diagnostic algorithm based on the broad etiologic categories of FUO that may be performed if a practitioner is suspicious for a particular disease process (Fig 2) . The recommended evaluation provides diagnostic "first steps" in the evaluation of these categories that may be performed before referral for specialized or invasive testing. This tiered approach to FUO can decrease overall costs and the use of invasive testing.
MANAGEMENT AND EMPIRIC TREATMENT
The initial management of FUO remains an area of debate. Pediatric FUO is often overtreated because most cases are caused by benign or nonacute disease. Physician concern for serious illness or parental pressure can lead to empiric treatment before sufficient evaluation. Physicians may be inclined to start antipyretics, corticosteroids, or antibiotics for an unknown disease process, which can affect future laboratory data, imaging, or treatment. Many cases of FUO resolve without a diagnosis and empiric treatment may mask the diagnosis of life-threatening oncologic, infectious, and autoimmune diseases. Empiric treatment should be initiated with caution and in conjunction with judicious testing.
The first step in the management of FUO is to discontinue all nonessential pharmacologic agents, including antipyretic medications. Drug fever can manifest at any time after starting a medication, with an overall incidence of up to 5%. (50) Drug fever is a common source of FUO and can be caused by any agent, including antibiotics, ibuprofen, and acetaminophen (Table 3) . Once the drug is discontinued, fever usually abates within 24 hours or two half-lives of the drug, typically resolving within 72 to 96 hours. (51) If drug fever is suspected and the patient is taking multiple medications, eliminating one drug at a time may be helpful in identifying the offending agent. However, other causes of fever should be explored, based on history and physical examination findings, when discontinuing the medication to ensure that fever resolution is due to drug fever rather than resolution of another cause.
In an otherwise healthy, well-appearing child with FUO, we do not recommend routine use of empiric antibiotics or anti-inflammatory agents. Empiric antibiotics can delay the diagnosis of common infectious causes of FUO, such as endocarditis, osteomyelitis, central nervous system infection, or abscesses. Pediatricians commonly prescribe tetracyclines (namely, doxycycline) or macrolides for presumed atypical bacterial infections in the absence of risk factors or clinical criteria for these diseases. These agents have activity against some typical bacteria and have limited antiinflammatory effects, which can delay the manifestation or natural disease process of alternative causes of FUO. (52)(53)(54) We recommend the use of these agents when there is high clinical suspicion and only after the diagnostic tests for the pathogen are obtained.
The decision to use empiric anti-inflammatory agents is challenging. Corticosteroids can play a significant role in treating certain causes of FUO, such as autoimmune disease. There is no urgency for empiric treatment in most autoimmune diseases, and treatment should be started after the diagnosis is confirmed. On one hand, corticosteroids affect a broad range of physiologic processes, including the immune system; can potentially increase the risk of acquiring an infection or worsen an underlying infection; and can impair the diagnostic usefulness of blood and tissue samples in oncologic testing and staging. On the other hand, immune suppression should not be a contraindication for specifically indicated short-term corticosteroids. Clinical immune suppression associated with corticosteroid use manifests after 14 to 21 days of daily administration. (55) (56)(57)(58) We recommend the use of corticosteroids if there is high suspicion for serious autoimmune and inflammatory conditions, such as systemic lupus erythematosus or JIA, but not until oncologic etiologies have been excluded.
PROGNOSIS AND OUTCOME
A major difference between adult and pediatric FUO is outcome. The prognosis of pediatric FUO is likely favorable compared to FUO in the adult population due to differences in causes. (59)(60) The original studies on pediatric FUO from the 1970s demonstrated a mortality rate of 6% to 9%. (12)(13) However, with the shifting causes of pediatric FUO, further study is needed to define outcomes in both adult and pediatric cases.
The increasing percentage of "undiagnosed" causes of FUO has influenced the previously documented pediatric mortality rates. Recent evidence suggests reassuring outcomes for undiagnosed pediatric FUO. Talano and Katz (17) followed 19 children with undiagnosed FUO for a median of 3.5 years. Sixteen of 19 (82%) children with initially undiagnosed FUO were afebrile and clinically healthy at longterm follow-up. Of the three children who remained febrile or were not clinically well, two were subsequently diagnosed with JIA and the other with intussusception. Similarly, Miller et al (16) studied 40 children referred to a rheumatology clinic for evaluation of FUO. Of the 40 children, 37 were available at long-term follow-up (median 60.5 months); 34 had complete resolution of fevers and 2 (5%) developed evidence of inflammatory bowel disease during follow-up. Of note, neither of these studies was powered for morbidity or mortality analysis. Whether the mortality rate of 6% to 9% found in previous studies applies to current cases of FUO is currently unknown, particularly given the evolving changes in underlying etiology over time. Further study is needed to determine the mortality and overall outcomes associated with pediatric FUO.
